(Q40480646)

20 September 2017

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. (English)

1 reference

20 September 2017

1 reference

1

Andrea Mariani

1 reference

20 September 2017

Sean C Dowdy

2

1 reference

20 September 2017

Gary L Keeney

3

1 reference

20 September 2017

Harry J Long

4

1 reference

20 September 2017

Timothy G Lesnick

5

1 reference

20 September 2017

Karl C Podratz

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

20 September 2017

1 reference

20 September 2017

95

1 reference

20 September 2017

1

1 reference

20 September 2017

120-126

1 reference

20 September 2017

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Hematogenous dissemination in corpus cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Surgical stage I endometrial cancer: predictors of distant failure and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Predictors of lymphatic failure in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Endometrial cancer: predictors of peritoneal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Pretreatment assessment of prognostic indicators in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Risk factors and recurrent patterns in Stage I endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Conservative management of stage I endometrial carcinoma after surgical staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Stage I corpus cancer: is teletherapy necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity. A prospective clinical trial at the Mayo Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.042

10.1016/J.YGYNO.2004.06.042

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference